Cargando…
Driving cancer evolution
Tumor-growth-factor-beta signaling helps cancer cells to evolve and become resistant to drugs by down-regulating accurate DNA repair.
Autores principales: | Fitzgerald, Devon M, Rosenberg, Susan M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5345930/ https://www.ncbi.nlm.nih.gov/pubmed/28282287 http://dx.doi.org/10.7554/eLife.25431 |
Ejemplares similares
-
Finding the mutations that drive resistance
por: Bley, Nadine
Publicado: (2020) -
Environmental cystine drives glutamine anaplerosis and sensitizes cancer cells to glutaminase inhibition
por: Muir, Alexander, et al.
Publicado: (2017) -
Bladder-cancer-associated mutations in RXRA activate peroxisome proliferator-activated receptors to drive urothelial proliferation
por: Halstead, Angela M, et al.
Publicado: (2017) -
Role of the oral microbiota in cancer evolution and progression
por: Sun, Jiwei, et al.
Publicado: (2020) -
Stroma-Mediated Breast Cancer Cell Proliferation Indirectly Drives Chemoresistance by Accelerating Tumor Recovery between Chemotherapy Cycles
por: Miroshnychenko, Daria, et al.
Publicado: (2023)